§ 16-41-17-10 — Follow-up programs; newborn screening fees; waste blood specimen confidentiality

(a) The state department shall develop the
following:
(1) A registry for tracking and follow-up of all newborns and
individuals for screening.
(2) A centralized program that provides follow-up, diagnosis,
management, and family counseling and support, including
equipment, supplies, formula, and other materials, for all infants
and individuals identified as having one (1) of the disorders listed
in section 2 of this chapter.
(3) A laboratory quality assurance program, including proficiency
testing.
(4) A statewide network of genetic evaluation and counseling
services.
(5) A system for using, for epidemiological survey and research
purposes, any waste blood specimen generated under this chapter.
(b) The program described in subsection (a) shall be funded by
collection of a newborn screening fee for each newborn screened by a
designated laboratory.
(c) The state department shall set the fee and procedures for
disbursement under rules adopted under IC 4-22-2. The fee must be
based upon the projected cost of the program. The proposed fee must
be approved by the budget agency before the rule is adopted.
(d) The designated laboratory shall assess, collect, and deposit the
fees established under subsection (c) in the newborn screening fund
established under section 11 of this chapter.
(e) The state department shall annually review the newborn
screening fee.
(f) Waste blood specimens used for the purpose of implementing the
system described under subsection (a)(5) may not include the name or
other identifying characteristics that would identify the individual
submitting the specimen.
[Pre-1993 Recodification Citation: 16-8-6-8 part.]

Legislative History

As added by P.L.2-1993, SEC.24.